IL164358A - Superantigen binding site within the cd28 molucule, peptides derived therefrom and uses thereof - Google Patents

Superantigen binding site within the cd28 molucule, peptides derived therefrom and uses thereof

Info

Publication number: IL164358A
Authority: IL; Israel
Prior art keywords: molucule; binding site; derived therefrom; peptides derived; superantigen binding
Prior art date: 2002-04-04

Application number

IL164358A

Original Assignee

Yissum Res Dev Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-04

Filing date

2004-09-28

Publication date

2013-02-28

2004-09-28 Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co

2004-09-28 Priority to IL164358A priority Critical patent/IL164358A/en

2013-02-28 Publication of IL164358A publication Critical patent/IL164358A/en

Links

101000686985 Mouse mammary tumor virus (strain C3H) Protein PR73 Proteins 0.000 title 1
102000004196 processed proteins & peptides Human genes 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1
231100000617 superantigen Toxicity 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70521—CD28, CD152
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Toxicology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Transplantation (AREA)
Cell Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

IL164358A 2002-04-04 2004-09-28 Superantigen binding site within the cd28 molucule, peptides derived therefrom and uses thereof IL164358A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
IL164358A IL164358A (en)	2002-04-04	2004-09-28	Superantigen binding site within the cd28 molucule, peptides derived therefrom and uses thereof

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL14899302A IL148993A0 (en)	2002-04-04	2002-04-04	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
PCT/IL2003/000278 WO2003084995A2 (en)	2002-04-04	2003-04-03	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
IL164358A IL164358A (en)	2002-04-04	2004-09-28	Superantigen binding site within the cd28 molucule, peptides derived therefrom and uses thereof

Publications (1)

Publication Number	Publication Date
IL164358A true IL164358A (en)	2013-02-28

Family

ID=28460340

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
IL14899302A IL148993A0 (en)	2002-04-04	2002-04-04	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
IL16435803A IL164358A0 (en)	2002-04-04	2003-04-03	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
IL164358A IL164358A (en)	2002-04-04	2004-09-28	Superantigen binding site within the cd28 molucule, peptides derived therefrom and uses thereof

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
IL14899302A IL148993A0 (en)	2002-04-04	2002-04-04	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
IL16435803A IL164358A0 (en)	2002-04-04	2003-04-03	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof

Country Status (6)

Country	Link
EP (1)	EP1492808A2 (en)
JP (2)	JP4624684B2 (en)
AU (1)	AU2003219489B2 (en)
CA (1)	CA2480598A1 (en)
IL (3)	IL148993A0 (en)
WO (1)	WO2003084995A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL148993A0 (en) *	2002-04-04	2002-11-10	Yissum Res Dev Co	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
WO2004087754A1 (en)	2003-04-03	2004-10-14	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
US8535672B2 (en)	2002-04-04	2013-09-17	Yissum Research Development Of The Hebrew University Of Jerusalem	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
PE20120341A1 (en)	2008-12-09	2012-04-24	Genentech Inc	ANTI-PD-L1 ANTIBODIES AND ITS USE TO IMPROVE T-CELL FUNCTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6060054A (en) *	1996-04-10	2000-05-09	National Jewish Medical And Research Center	Product for T lymphocyte immunosuppression
IL119938A (en) *	1996-12-30	2005-08-31	Yissum Res Dev Co	Peptides capable of eliciting protective immunity against toxic shock induced by pyrogenic exotoxins or of antagonizing toxin-mediated activation of t cells
ATE264688T1 (en) *	1997-06-12	2004-05-15	Applied Research Systems	CD28/CTLA-4 INHIBITING PEPTIDOMIMETICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
IL148993A0 (en) *	2002-04-04	2002-11-10	Yissum Res Dev Co	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
WO2004087754A1 (en) *	2003-04-03	2004-10-14	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof

2002
- 2002-04-04 IL IL14899302A patent/IL148993A0/en unknown
2003
- 2003-04-03 CA CA002480598A patent/CA2480598A1/en not_active Abandoned
- 2003-04-03 EP EP03715301A patent/EP1492808A2/en not_active Withdrawn
- 2003-04-03 AU AU2003219489A patent/AU2003219489B2/en not_active Ceased
- 2003-04-03 IL IL16435803A patent/IL164358A0/en unknown
- 2003-04-03 WO PCT/IL2003/000278 patent/WO2003084995A2/en active Application Filing
- 2003-04-03 JP JP2003582189A patent/JP4624684B2/en not_active Expired - Fee Related
2004
- 2004-09-28 IL IL164358A patent/IL164358A/en not_active IP Right Cessation
2010
- 2010-03-25 JP JP2010070685A patent/JP2010195797A/en active Pending

Also Published As

Publication number	Publication date
AU2003219489B2 (en)	2010-04-15
JP2010195797A (en)	2010-09-09
IL148993A0 (en)	2002-11-10
EP1492808A2 (en)	2005-01-05
IL164358A0 (en)	2005-12-18
WO2003084995A2 (en)	2003-10-16
AU2003219489A1 (en)	2003-10-20
JP2006505500A (en)	2006-02-16
JP4624684B2 (en)	2011-02-02
WO2003084995A3 (en)	2003-12-18
CA2480598A1 (en)	2003-10-16

Legal Events

Date	Code	Title
2013-06-27	FF	Patent granted
2013-06-27	MM9K	Patent not in force due to non-payment of renewal fees
2013-07-31	KB	Patent renewed
2017-03-30	KB	Patent renewed
2021-04-29	KB	Patent renewed

Publication	Publication Date	Title
IL200404A0 (en)	2010-04-29	191P4D12(b) PROTEINS, POLYNUCLEOTIDES ENCODING THE SAME; ANTIBODIES BINDING THERETO AND USES THEREOF
DE60223699D1 (en)	2008-01-03	Diarylsulfidderivat, dessen additionssalz und immunsuppressivum
EP2949658A3 (en)	2016-01-13	Peptides that specifically bind HGF receptor (cMet) and uses thereof
EP1578930A4 (en)	2008-07-02	Cngh0004 polypeptides, antibodies, compositions, methods and uses
IL162137A0 (en)	2005-11-20	D-ribofuranosylthiazolo -3-Ä4,5-dÜpyridimine nucl eosides and uses thereof
WO2004048399A3 (en)	2005-12-22	Skin or hair binding peptides
TWI347349B (en)	2011-08-21	Organometal complex, electroluminescence material using the complex and electroluminescence element using the complex
EP1539792A4 (en)	2005-12-21	Cngh0005 polypeptides, antibodies, compositions, methods and uses
IL177223A (en)	2015-10-29	Tat complexes, vaccines containing the same and uses thereof
IL156263A0 (en)	2004-01-04	Livin-derived peptides, compositions and uses thereof
AU2003228863A8 (en)	2003-11-17	Immunogenic peptides
IL164358A (en)	2013-02-28	Superantigen binding site within the cd28 molucule, peptides derived therefrom and uses thereof
AU2003285892A8 (en)	2004-05-04	Bace binding peptides and uses thereof
AU2003299336A8 (en)	2004-07-14	Diphosphines, preparation and uses thereof
EP1660088A4 (en)	2009-04-29	Pyridomorphinans, pyridazinomorphinans and use thereof
EP1487547A4 (en)	2010-09-15	Physical interaction means and related uses thereof
AU2003275127A8 (en)	2004-04-08	P. ariasi polypeptides, p. perniciosus polypeptides and methods of use
GB2393687B (en)	2004-10-20	Punchless file
HK1060335A1 (en)	2004-08-06	Binding implement.
GB0312992D0 (en)	2003-07-09	Peptides,compositions and uses thereof
GB0321401D0 (en)	2003-10-15	Antibodies,polypeptides and uses thereof
GB0218515D0 (en)	2002-09-18	S.d.s.
AU2003267162A8 (en)	2004-04-30	Cancer associated antigens, sga-56m and sga-56mv, and uses thereof
EP1482048A4 (en)	2007-07-11	Sulfotransferase, its polypeptide and dna encoding the same
TW528001U (en)	2003-04-11	Improved nail file